Isto Biologics products
Isto Biologics is an orthobiologics company dedicated to improving patient quality of life by using the science of human biology to advance solutions for spine, orthopedics, and sports medicine. Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading Magellan® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system.
Magellan is a fully-automated concentration system optimized to provide high concentrations of platelets and cells for orthopedic applications.
Magellan is a fully-automated concentration system optimized to provide high concentrations of platelets and cells for orthopedic applications.
The Lightning Bone Marrow Aspiration Cannula System is a single use, disposable device that contains eight large, bevel-edged fenestrations allowing for gentle bone marrow aspiration.
InQu Bone Graft Extender & Substitute combines a biologic molecule with the consistency and cost effectiveness of a synthetic to create a new category of bone graft: Biosynthetic.
Influx DBM is a fully moldable, demineralized bone graft that utilizes proprietary processing of demineralized cortical fibers and demineralized cortical particulate to produce a positive osteoinductive response